Treatment of Acute Respiratory Failure Due to Pulmonary Embolism
Initial Management
- The European Society of Cardiology recommends immediate anticoagulation with heparin, oxygen therapy to maintain saturation ≥90%, and risk stratification to determine the need for reperfusion therapy in high-risk patients 1, 2, 3
- Provide supplemental oxygen to maintain target saturation of 94-98% (or 88-92% if at risk of hypercapnic respiratory failure) 4
- Consider high-flow oxygen via nasal cannula if conventional oxygen therapy is insufficient 3, 4
- Use non-invasive ventilation when possible before resorting to intubation 5, 4
- If intubation becomes necessary, avoid anesthetic drugs prone to cause hypotension, use tidal volumes of approximately 6 mL/kg lean body weight, and apply positive end-expiratory pressure cautiously as it may worsen RV failure 5, 4
Anticoagulation
- Initiate anticoagulation therapy immediately upon suspicion of PE, unless bleeding or absolute contraindications exist 1, 2
- Prefer NOACs (Novel Oral Anticoagulants) over traditional LMWH-VKA regimen for longer-term management unless contraindicated 1, 2
Risk Stratification and Specific Management
- Perform bedside echocardiography immediately to differentiate PE from other life-threatening conditions in high-risk patients 1, 2
- Select appropriate reperfusion option based on patient risk profile and available resources in high-risk patients 1, 2
- Assess RV function using imaging and laboratory biomarkers in intermediate-high risk PE patients 1, 2, 5
- Monitor closely for signs of deterioration in intermediate-high risk PE patients 1, 2
Management of Right Ventricular Failure
- If central venous pressure is low, consider modest fluid challenge (≤500 mL) 5
- Avoid aggressive volume expansion as it may worsen RV function 5
- Consider vasopressors (norepinephrine 0.2-1.0 mg/kg/min) for patients in cardiogenic shock 3, 5
- Consider dobutamine for patients with low cardiac index but normal blood pressure 5
Special Considerations
- Re-examine patient after 3-6 months of anticoagulation to assess benefits vs. risks of continuing treatment 2
- Screen for persisting or new-onset dyspnea or functional limitation 2
- Implement staged diagnostic workup if symptoms persist to exclude chronic thromboembolic pulmonary hypertension 2
Common Pitfalls
- Delaying anticoagulation while waiting for diagnostic confirmation 1, 2
- Excessive fluid administration worsening RV function 5
- Failing to consider intracardiac shunting in cases of refractory hypoxemia 5
- Missing the diagnosis of subsegmental PE (consider discussing with radiologist or seeking second opinion) 1, 2